K. Michael Conaway sold Biomarin Pharmaceutical Inc (NASDAQ: BMRN)
K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 1 trade in Biomarin Pharmaceutical Inc (BMRN) since 2016, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: K. Michael Conaway sold $1,001 - $15,000 of Biomarin Pharmaceutical Inc (NASDAQ: BMRN) on September 12, 2016. Since that trade, BMRN is down -37.05% against the S&P 500 up +301.45%, an outperformance of -338.50%.
Data updated
K. Michael Conaway's BMRN trades vs the price
BMRN is down -37.05% since K. Michael Conaway sold on September 12, 2016, versus +301.45% for the S&P 500.
Performance since this trade
All K. Michael Conaway BMRN trades
K. Michael Conaway & BMRN trading FAQ
Is it legal for K. Michael Conaway to trade Biomarin Pharmaceutical Inc (BMRN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Biomarin Pharmaceutical Inc (BMRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did K. Michael Conaway sell BMRN?
K. Michael Conaway disclosed a sale of $1,001 - $15,000 of Biomarin Pharmaceutical Inc (BMRN) on September 12, 2016, according to public STOCK Act filings.
How has BMRN performed since K. Michael Conaway's trade?
Since K. Michael Conaway sold BMRN on September 12, 2016, the stock is down -37.05%, versus +301.45% for the S&P 500 over the same period, an outperformance of -338.50%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMRN trades?
Quantellect tracks every disclosed congressional trade in Biomarin Pharmaceutical Inc (BMRN) on the Biomarin Pharmaceutical Inc congressional trading page, which aggregates filings across all members of Congress.
K. Michael Conaway's BMRN tradesAll congressional filings for Biomarin Pharmaceutical IncK. Michael Conaway's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.